Fig. 1From: CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trialConsolidated Standards of Reporting Trials (CONSORT) flow diagram of subject disposition; mITT: modified intent-to-treatBack to article page